Kestra Advisory Services, LLC Cidara Therapeutics, Inc. Transaction History

Kestra Advisory Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.01 - $1.42 $50,869 - $71,519	50,366 Added 192.72%	76,500 $86,000
Q1 2023 May 12, 2023	BUY	$0.75 - $1.98 $19,600 - $51,745	26,134 New	26,134 $33,000
Q1 2022 Apr 26, 2022	SELL	$0.67 - $1.39 $11,390 - $23,630	-17,000 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$1.18 - $2.18 $15,930 - $29,430	-13,500 Reduced 44.26%	17,000 $21,000
Q3 2021 Oct 19, 2021	BUY	$1.48 - $2.35 $45,140 - $71,675	30,500 New	30,500 $68,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.24B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.